Product How it works Pricing Blog FAQ About Contact
Harmony Biosciences

Harmony Biosciences (NASDAQ: HRMY) revenue

Harmony Biosciences reported revenue of $868.5m for fiscal 2025, 21.5% more than in fiscal 2024 ($714.7m). Since fiscal 2019 its revenue has grown by 14,386.3%, an average growth of 129.2% a year.

Harmony Biosciences has grown its revenue for 6 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record.

Revenue, in millions of US dollars6.02019159.72020305.42021437.92022582.02023714.72024868.52025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$868.5m+21.5%$208.5m24.0%
2024$714.7m+22.8%$190.8m26.7%
2023$582.0m+32.9%$192.0m33.0%
2022$437.9m+43.4%$120.2m27.4%
2021$305.4m+91.2%$87.5m28.7%
2020$159.7m+2,564.6%$17.0m10.6%
2019$6.0m—−$145.9m−2,433.8%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Harmony Biosciences revenue compared with its sector

By revenue for its latest fiscal year, Harmony Biosciences ranks 162nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Harmony Biosciences, 21.5%.

RankCompanyRevenueRevenue growth
160thWarby Parker$871.9m13.0%
161stNeogen$870.4m−2.7%
162ndHarmony Biosciences$868.5m21.5%
163rdVarex Imaging$844.6m4.1%
164thArrowhead Pharmaceuticals$829.4m23,258.2%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Harmony Biosciences

How much revenue did Harmony Biosciences make in fiscal 2025?
Harmony Biosciences reported revenue of $868.5m for fiscal 2025, compared with $714.7m in fiscal 2024.
How much has the revenue of Harmony Biosciences grown?
Between fiscal 2019 and fiscal 2025 it went from $6.0m to $868.5m: 14,386.3% more, an average growth of 129.2% a year.
What was the best year for revenue at Harmony Biosciences?
Of its last 7 fiscal years, fiscal 2025, with $868.5m.
Where does Harmony Biosciences rank in its sector by revenue?
It ranks 162nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Harmony Biosciences come from?
From the annual report (Form 10-K) that Harmony Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Harmony Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Harmony Biosciences: the Harmony Biosciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.